CASIRAGHI, VALERIA
 Distribuzione geografica
Continente #
AS - Asia 1.915
NA - Nord America 1.374
EU - Europa 1.214
SA - Sud America 155
OC - Oceania 107
AF - Africa 43
Totale 4.808
Nazione #
US - Stati Uniti d'America 1.302
CN - Cina 547
IT - Italia 541
SG - Singapore 478
BD - Bangladesh 199
GB - Regno Unito 136
HK - Hong Kong 126
BR - Brasile 123
VN - Vietnam 120
DE - Germania 111
JP - Giappone 109
IN - India 108
AU - Australia 93
NL - Olanda 80
KR - Corea 79
RU - Federazione Russa 79
FR - Francia 69
TR - Turchia 54
CA - Canada 46
FI - Finlandia 39
ES - Italia 35
CH - Svizzera 22
CI - Costa d'Avorio 19
MX - Messico 14
NZ - Nuova Zelanda 14
PL - Polonia 13
ZA - Sudafrica 13
PK - Pakistan 12
SE - Svezia 12
TW - Taiwan 12
ID - Indonesia 11
MY - Malesia 11
AR - Argentina 10
BE - Belgio 10
CZ - Repubblica Ceca 10
IR - Iran 9
CO - Colombia 8
NO - Norvegia 8
PH - Filippine 8
AT - Austria 7
HR - Croazia 7
IE - Irlanda 6
PT - Portogallo 6
SA - Arabia Saudita 6
EC - Ecuador 5
GR - Grecia 5
HU - Ungheria 4
IL - Israele 4
IQ - Iraq 4
MO - Macao, regione amministrativa speciale della Cina 4
CL - Cile 3
CR - Costa Rica 3
EG - Egitto 3
GT - Guatemala 3
LU - Lussemburgo 3
MA - Marocco 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DZ - Algeria 2
HN - Honduras 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
PY - Paraguay 2
TH - Thailandia 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
NI - Nicaragua 1
PE - Perù 1
PR - Porto Rico 1
SV - El Salvador 1
UA - Ucraina 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.808
Città #
Ashburn 203
Singapore 198
Hefei 145
Milan 141
Dallas 133
San Jose 116
Hong Kong 94
Beijing 86
Santa Clara 85
Los Angeles 70
Rome 54
Tokyo 49
New York 48
Boardman 46
Hanoi 43
Sydney 42
Seoul 40
Council Bluffs 39
Bengaluru 37
Ho Chi Minh City 32
Buffalo 31
Munich 28
Lauterbourg 25
Guangzhou 24
Frankfurt am Main 22
Moscow 22
Ponte San Pietro 22
Helsinki 21
Melbourne 21
Sheffield 21
Abidjan 19
Cambridge 19
São Paulo 19
Istanbul 18
Körfez 17
Suwon 17
Amsterdam 16
Utrecht 15
Auckland 14
Orem 14
Wollongong 14
Atlanta 13
Baltimore 13
Chennai 13
Paris 13
San Cataldo 13
Fort Lauderdale 12
London 12
Madrid 12
Pavia 12
Naples 11
Oxford 11
Pittsburgh 11
Bari 10
Florence 10
Philadelphia 10
Southwark 10
Framingham 9
Greenwich 9
Mumbai 9
San Francisco 9
Bologna 8
Brisbane 8
Brooklyn 8
City of London 8
Hangzhou 8
Hyderabad 8
Jakarta 8
Montreal 8
Pasadena 8
Rostock 8
San Diego 8
Trondheim 8
Turin 8
Washington 8
Bergamo 7
Boston 7
Chicago 7
Falkenstein 7
Fukuoka 7
Houston 7
Kent 7
Mainz 7
Rio de Janeiro 7
Toronto 7
Warsaw 7
Wuhan 7
Barcelona 6
Brighton 6
Dublin 6
Ithaca 6
Johannesburg 6
Keltern 6
Kuala Selangor 6
Lappeenranta 6
New Delhi 6
Osaka 6
Queenstown Estate 6
Stockholm 6
Tianjin 6
Totale 2.616
Nome #
Modeling of TDP-43 proteinopathy by chronic oxidative stress identifies rapamycin as beneficial in ALS patient-derived 2D and 3D iPSC models 639
AGGREGATION MECHANISMS OF TDP-43 PROTEIN IN RESPONSE TO STRESS IN AMYOTROPHIC LATERAL SCLEROSIS AND THERAPEUTIC APPROACHES 421
Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis 277
Induced Pluripotent Stem Cell (iPSC)-derived Microglia and Organoids for neuronal disease modeling 254
Unraveling the role of primary cilia in the pathogenesis of amyotrophic lateral sclerosis 233
Unraveling the role of NEK1 on primary cilia using mutant iPSC models 224
Modelling ALS disease by 2D and 3D in vitro models of patient-derived iPSC 219
Exploring epigenetic drift and rare epivariations in amyotrophic lateral sclerosis by epigenome-wide association study 171
Characterization of human healthy i3 lower motor neurons exposed to CSF from ALS patients stratified by UNC13A and C9ORF72 genotype 163
Rapamycin reverts TDP-43 splicing defects and mislocalization in human in vitro models of TDP-43 proteinopathy 159
Quantification of serum TDP-43 and neurofilament light chain in patients with amyotrophic lateral sclerosis stratified by UNC13A genotype 140
U1 snRNA as a novel RNA-based therapeutic approach to modulate C9ORF72 pathology in patient-derived iPSC-motoneurons 135
Rapamycin reverts TDP-43 splicing defects and oxidative stress-induced alterations in a human in vitro model of TDP-43 proteinopathy 127
Rapamycin reverts TDP-43 splicing defects and mislocalization in human in vitro models of TDP-43 proteinopathy 122
Modelling ALS disease by 3D organoids culture from human-derived iPSC 121
Induced Pluripotent Stem Cell (iPSC)-derived Microglia for ALS modeling 117
NEK1 loss-of-function mutation impairs ciliogenesis in iPSC-motoneurons 115
Characterization of human healthy i3 lower motor neurons exposed to CSF from ALS patients stratified by UNC13A and C9ORF72 genotype 115
Human in vitro models of TDP-43 proteinopathy for drug screening approaches 113
U1 snRNA as a novel RNA-based therapeutic approach to modulate C9ORF72 pathology in patient-derived iPSC-motoneurons 112
Characterization of human i3 motor neurons exposed to CSF from ALS patients stratified by C9ORF72 and UNC13A genotype 102
Induced Pluripotent Stem Cell (iPSC)-derived Microglia for ALS modeling 98
Rapamycin reverts TDP-43 splicing defects and mislocalization in human in vitro models of TDP-43 proteinopathy 97
Defective primary cilia in NEK1 and C9ORF72 iPSC-derived motoneurons and brain organoids 93
Characterization of human i3 motor neurons exposed to CSF from ALS patients stratified by C9ORF72 and UNC13A genotype 92
NEK1 haploinsufficiency worsens DNA damage, but not defective ciliogenesis, in C9ORF72 patient-derived iPSC-motoneurons 88
Modeling a novel N-terminal mutation of KIF5A gene in patient-derived iPSC-motoneurons 88
Characterization of human i3 motor neurons exposed to CSF from ALS patients stratified by C9ORF72 and UNC13A genotype 87
Induced Pluripotent Stem Cell (iPSC)-derived Microglia for ALS modeling 86
Defective primary cilia in NEK1 and C9ORF72 iPSC-derived motoneurons and brain organoids 83
Analysis of normal C9orf72 repeat length as possible disease modifier in amyotrophic lateral sclerosis 30
Functional validation of the novel KIF5A p.R17Q VUS reveals defective axonal transport in iPSC-motoneurons from a SPG10 patient 19
Totale 4.940
Categoria #
all - tutte 10.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.751


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202331 0 0 0 0 0 0 0 1 14 12 2 2
2023/2024217 1 1 2 9 6 5 2 4 14 14 112 47
2024/2025846 51 65 25 51 27 29 51 50 35 84 99 279
2025/20263.846 349 370 535 374 201 196 366 148 328 255 362 362
Totale 4.940